|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 116, 844-853, Copyright © 1998 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
NOTE: Fulltext is available only in pdf format
PW Vriens, FG Blankenberg, JH Stoot, K Ohtsuki, GJ Berry, JF Tait, HW Strauss and RC Robbins
OBJECTIVE: Apoptosis, or programmed cell death, has been suggested as a
mechanism of immunologic injury during cardiac allograft rejection. We
tested the hypothesis that technetium Tc 99m annexin V, a novel
radiopharmaceutical used to detect apoptosis, can be used to detect cardiac
allograft rejection by nuclear imaging. METHODS: Untreated ACI rats served
as recipients of allogeneic PVG rat (n = 66) or syngeneic ACI rat (n = 30)
cardiac grafts. Untreated recipient animals underwent 99mTc-annexin V
imaging daily for 7 days. Region of interest analysis was used to quantify
the uptake of 99mTc-annexin V. Immediately after imaging grafts were
procured for histopathologic analysis and terminal
deoxynucleotidyltransferase-mediated deoxyuridine triphosphate-biotin
nick-end labeling of apoptotic nuclei. One group was treated with 10
mg/kg/d cyclosporine (INN: ciclosporin) commencing on day 4 after
transplantation (n = 6). RESULTS: Untreated allografts showed histologic
signs of rejection 4 days after transplantation. Apoptotic nuclei could be
demonstrated in myocytes, endothelial cells, and graft- infiltrating cells
of all rejecting allografts. Nuclear imaging revealed a significantly
greater uptake of 99mTc-annexin V in rejecting allogeneic grafts than in
syngeneic grafts on day 4 (P = .05), day 5 (P < .001), day 6 (P <
.001), and day 7 (P = .013) after transplantation. A correlation between
the histologic grade of acute rejection and uptake of 99mTc-annexin V was
observed (r2 = 0.87). After treatment of rejection with cyclosporine, no
apoptotic nuclei could be identified in allografts and uptake of
99mTc-annexin V decreased to baseline. CONCLUSIONS: Apoptosis occurs during
acute cardiac allograft rejection and disappears after treatment of
rejection. 99mTc-annexin V can be used to detect and monitor cardiac
allograft rejection.
ARTICLES
The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection
Department of Cardiothoracic Surgery, Stanford University Medical Center, Calif 94305-5407, USA.
This article has been cited by other articles:
![]() |
H. Steen, C. Merten, S. Refle, R. Klingenberg, T. Dengler, E. Giannitsis, and H. A. Katus Prevalence of Different Gadolinium Enhancement Patterns in Patients After Heart Transplantation J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1160 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Boersma, B. L.J.H. Kietselaer, L. M.L. Stolk, A. Bennaghmouch, L. Hofstra, J. Narula, G. A.K. Heidendal, and C. P.M. Reutelingsperger Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications J. Nucl. Med., December 1, 2005; 46(12): 2035 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model J. Nucl. Med., December 1, 2004; 45(12): 2083 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Taki, T. Higuchi, A. Kawashima, J. F. Tait, S. Kinuya, A. Muramori, I. Matsunari, K. Nakajima, N. Tonami, and H. W. Strauss Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V J. Nucl. Med., September 1, 2004; 45(9): 1536 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bennink, M. J. van den Hoff, F. J. van Hemert, K. M. de Bruin, A. L. Spijkerboer, J.-L. Vanderheyden, N. Steinmetz, and B. L. van Eck-Smit Annexin V Imaging of Acute Doxorubicin Cardiotoxicity (Apoptosis) in Rats J. Nucl. Med., May 1, 2004; 45(5): 842 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Britz-Cunningham and S. J. Adelstein Molecular Targeting with Radionuclides: State of the Science J. Nucl. Med., December 1, 2003; 44(12): 1945 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petrovsky, E. Schellenberger, L. Josephson, R. Weissleder, and A. Bogdanov Jr. Near-Infrared Fluorescent Imaging of Tumor Apoptosis Cancer Res., April 15, 2003; 63(8): 1936 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Yang, C.-G. Kim, N. R. Schechter, A. Azhdarinia, D.-F. Yu, C.-S. Oh, J. L. Bryant, J.-J. Won, E. E. Kim, and D. A. Podoloff Imaging with 99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents Radiology, February 1, 2003; 226(2): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mochizuki, Y. Kuge, S. Zhao, E. Tsukamoto, M. Hosokawa, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V J. Nucl. Med., January 1, 2003; 44(1): 92 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Post, P. D. Katsikis, J. F. Tait, S. M. Geaghan, H. W. Strauss, and F. G. Blankenberg Imaging Cell Death with Radiolabeled Annexin V in an Experimental Model of Rheumatoid Arthritis J. Nucl. Med., October 1, 2002; 43(10): 1359 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, and A. Green Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis Clin. Cancer Res., September 1, 2002; 8(9): 2766 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Russell, J. A. O'Donoghue, R. Finn, J. Koziorowski, S. Ruan, J. L. Humm, and C. C. Ling Iodination of Annexin V for Imaging Apoptosis J. Nucl. Med., May 1, 2002; 43(5): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Blankenberg, L. Naumovski, J. F. Tait, A. M. Post, and H. W. Strauss Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V J. Nucl. Med., February 1, 2001; 42(2): 309 - 316. [Abstract] [Full Text] |
||||
![]() |
C. H. Contag, S. Fraser, and R. Weissleder Strategies in In Vivo Molecular Imaging NeoReviews, December 1, 2000; 1(12): e225 - 232. [Full Text] |
||||
![]() |
C. H. Contag, R. Weissleder, M. H. Bachmann, and S. E. Fraser Applications of In Vivo Molecular Imaging in Biology and Medicine NeoReviews, December 1, 2000; 1(12): e233 - 240. [Full Text] |
||||
![]() |
H. D'Arceuil, W. Rhine, A. de Crespigny, M. Yenari, J. F. Tait, W. H. Strauss, T. Engelhorn, A. Kastrup, M. Moseley, F. G. Blankenberg, et al. 99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury Editorial Comment Stroke, November 1, 2000; 31(11): 2692 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Blankenberg, R. C. Robbins, J. H. Stoot, P. W. Vriens, G. J. Berry, J. F. Tait, and H. W. Strauss Radionuclide Imaging of Acute Lung Transplant Rejection With Annexin V Chest, March 1, 2000; 117(3): 834 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ogura, S. M. Krams, O. M. Martinez, S. Kopiwoda, J. P. T. Higgins, C. O. Esquivel, H. W. Strauss, J. F. Tait, and F. G. Blankenberg Radiolabeled Annexin V Imaging: Diagnosis of Allograft Rejection in an Experimental Rodent Model of Liver Transplantation Radiology, March 1, 2000; 214(3): 795 - 800. [Abstract] [Full Text] |
||||
![]() |
W. L van Heerde, S. Robert-Offerman, E. Dumont, L. Hofstra, P. A Doevendans, J. F.M Smits, M. J.A.P Daemen, and C. P.M Reutelingsperger Markers of apoptosis in cardiovascular tissues: focus on Annexin V Cardiovasc Res, February 1, 2000; 45(3): 549 - 559. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |